Roivant Sciences Ltd. · NASDAQ:ROIV

Epperly Melissa B, sold 17,750 Roivant Sciences Ltd. shares (Form 4)

Traded Jun 29, 2026 · Filed Jul 1, 2026

On Jun 29, 2026, Epperly Melissa B, (Director) sold 17,750 Roivant Sciences Ltd. shares at an average US$34.38 for US$610K under a trading plan, leaving 16,474 shares. Filed Jul 1, 2026 (Form 4).

Sold
17,750 shares
Price
US$34.38 average (US$34.32 to US$34.71)
Value
US$610K
Holding after
16,474 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 29, 2026Common SharesOption exercise17,750US$4.4634,224Direct
Jun 29, 2026Common SharesSale15,002US$34.3219,222Direct
Jun 29, 2026Common SharesSale2,748US$34.7116,474Direct

Source

View original at SEC

Related